Comment on

• Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes.

  Swystun LL, Shin LY, Beaudin S, Liaw PC. Swystun LL, et al. J Thromb Haemost. 2009 Apr;7(4):619-26. doi: 10.1111/j.1538-7836.2009.03300.x. Epub 2009 Jan 24. J Thromb Haemost. 2009. PMID: 19187077
• From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism?

  Borissoff JI, ten Cate H. Borissoff JI, et al. J Thromb Haemost. 2011 Sep;9(9):1791-4. doi: 10.1111/j.1538-7836.2011.04425.x. J Thromb Haemost. 2011. PMID: 21718435 No abstract available.
• Tissue factor and cell signalling in cancer progression and thrombosis.

  Ruf W, Disse J, Carneiro-Lobo TC, Yokota N, Schaffner F. Ruf W, et al. J Thromb Haemost. 2011 Jul;9 Suppl 1(Suppl 1):306-15. doi: 10.1111/j.1538-7836.2011.04318.x. J Thromb Haemost. 2011. PMID: 21781267 Free PMC article. Review.
• Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus.

  Swystun LL, Mukherjee S, Liaw PC. Swystun LL, et al. J Thromb Haemost. 2011 Nov;9(11):2313-21. doi: 10.1111/j.1538-7836.2011.04465.x. J Thromb Haemost. 2011. PMID: 21838758